| Dr Ryan Matthew Orgel, MD | |
|
3000 New Bern Ave, Raleigh, NC 27610-1231 | |
| (919) 350-8000 | |
| Not Available |
| Full Name | Dr Ryan Matthew Orgel |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 10 Years |
| Location | 3000 New Bern Ave, Raleigh, North Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013336015 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Wakemed, Raleigh Campus | Raleigh, NC | Hospital |
| Wakemed, Cary Hospital | Cary, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Duke Health Integrated Practice Inc | 8325412737 | 2551 |
| Wakemed Specialists Group Llc | 2466788377 | 690 |
News Archive
Researchers funded by the Canadian Institutes of Health Research (CIHR) and the Canadian Diabetes Association (CDA) have identified an unsuspected role of a protein named SHP-1 that could constitute a new therapeutic path against Type 2 Diabetes.
The U.S. Food and Drug Administration today issued new scientific recommendations aimed at encouraging more widespread innovation and development of novel medication-assisted treatment drugs for the treatment of opioid use disorder.
In 2006, researchers published a widely reported study showing that for many patients who had suffered a heart attack more than 24 hours before and had a blocked coronary artery, certain heart procedures, such as balloon angioplasty and the insertion of stents, were no more effective than drugs alone. In 2007, the American Heart Association and the American College of Cardiology issued guidelines urging doctors to not use such treatments in those patients.
Scientists from the School of Biomedicine of Far Eastern Federal University (FEFU) with colleagues from Italy, Spain, Romania, and Sweden suggest a way to protect the brain and minimize neurodegenerative processes after concussion head injuries in the presence of extensive previous sleep deprivation.
› Verified 4 days ago
| Entity Name | Private Diagnostic Clinic Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457389033 PECOS PAC ID: 1355254368 Enrollment ID: O20031204000577 |
News Archive
Researchers funded by the Canadian Institutes of Health Research (CIHR) and the Canadian Diabetes Association (CDA) have identified an unsuspected role of a protein named SHP-1 that could constitute a new therapeutic path against Type 2 Diabetes.
The U.S. Food and Drug Administration today issued new scientific recommendations aimed at encouraging more widespread innovation and development of novel medication-assisted treatment drugs for the treatment of opioid use disorder.
In 2006, researchers published a widely reported study showing that for many patients who had suffered a heart attack more than 24 hours before and had a blocked coronary artery, certain heart procedures, such as balloon angioplasty and the insertion of stents, were no more effective than drugs alone. In 2007, the American Heart Association and the American College of Cardiology issued guidelines urging doctors to not use such treatments in those patients.
Scientists from the School of Biomedicine of Far Eastern Federal University (FEFU) with colleagues from Italy, Spain, Romania, and Sweden suggest a way to protect the brain and minimize neurodegenerative processes after concussion head injuries in the presence of extensive previous sleep deprivation.
› Verified 4 days ago
| Entity Name | Duke Health Integrated Practice Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205553369 PECOS PAC ID: 8325412737 Enrollment ID: O20230327002247 |
News Archive
Researchers funded by the Canadian Institutes of Health Research (CIHR) and the Canadian Diabetes Association (CDA) have identified an unsuspected role of a protein named SHP-1 that could constitute a new therapeutic path against Type 2 Diabetes.
The U.S. Food and Drug Administration today issued new scientific recommendations aimed at encouraging more widespread innovation and development of novel medication-assisted treatment drugs for the treatment of opioid use disorder.
In 2006, researchers published a widely reported study showing that for many patients who had suffered a heart attack more than 24 hours before and had a blocked coronary artery, certain heart procedures, such as balloon angioplasty and the insertion of stents, were no more effective than drugs alone. In 2007, the American Heart Association and the American College of Cardiology issued guidelines urging doctors to not use such treatments in those patients.
Scientists from the School of Biomedicine of Far Eastern Federal University (FEFU) with colleagues from Italy, Spain, Romania, and Sweden suggest a way to protect the brain and minimize neurodegenerative processes after concussion head injuries in the presence of extensive previous sleep deprivation.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ryan Matthew Orgel, MD Po Box 603949, Charlotte, NC 28260-3949 Ph: (919) 350-2266 | Dr Ryan Matthew Orgel, MD 3000 New Bern Ave, Raleigh, NC 27610-1231 Ph: (919) 350-8000 |
News Archive
Researchers funded by the Canadian Institutes of Health Research (CIHR) and the Canadian Diabetes Association (CDA) have identified an unsuspected role of a protein named SHP-1 that could constitute a new therapeutic path against Type 2 Diabetes.
The U.S. Food and Drug Administration today issued new scientific recommendations aimed at encouraging more widespread innovation and development of novel medication-assisted treatment drugs for the treatment of opioid use disorder.
In 2006, researchers published a widely reported study showing that for many patients who had suffered a heart attack more than 24 hours before and had a blocked coronary artery, certain heart procedures, such as balloon angioplasty and the insertion of stents, were no more effective than drugs alone. In 2007, the American Heart Association and the American College of Cardiology issued guidelines urging doctors to not use such treatments in those patients.
Scientists from the School of Biomedicine of Far Eastern Federal University (FEFU) with colleagues from Italy, Spain, Romania, and Sweden suggest a way to protect the brain and minimize neurodegenerative processes after concussion head injuries in the presence of extensive previous sleep deprivation.
› Verified 4 days ago
Dr. William Brooks Hall, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2605 Blue Ridge Rd Ste 190, Raleigh, NC 27607 Phone: 919-784-7460 | |
Dr. Serdal Aktolga, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3000 New Bern Ave, Raleigh, NC 27610 Phone: 919-350-8000 Fax: 919-350-7204 | |
Sheila A Munday, Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3101 John Humphries Wynd, Raleigh, NC 27612 Phone: 919-881-8272 Fax: 919-881-2026 | |
Dr. James Robert Foster, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 3000 New Bern Ave, G-100, Raleigh, NC 27610 Phone: 919-231-8253 Fax: 919-231-9546 | |
Dr. Michael Joseph Casey, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3604 Bush St, 2nd Floor, Raleigh, NC 27609 Phone: 919-876-7807 Fax: 919-876-8823 | |
Adnan Pervez, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2605 Blue Ridge Rd Ste 190, Raleigh, NC 27607 Phone: 919-784-7460 Fax: 919-784-5698 | |
Dr. Morgan Eileen Mullaney, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 4420 Lake Boone Trl Ste 420, Raleigh, NC 27607 Phone: 919-784-3100 |